Table 1.

Baseline characteristics stratified by breast WAT inflammation

Breast WAT Inflammation
CharacteristicsAbsent (n = 44)Present (n = 28)P
BMI, kg/m2
 Median (range)21.8 (17.3–24.6)23.0 (18.4–24.9)0.04
Age, y
 Median (range)47 (31–63)49 (31–64)0.26
Menopause, n (%)
 Pre35 (80%)19 (68%)
 Post9 (20%)9 (32%)0.28
Race, n (%)
 Caucasian34 (89%)21 (88%)
 Black1 (3%)0 (0%)
 Asian1 (3%)3 (12%)
 Other2 (5%)0 (0%)0.36
 Not reported7 (16%)3 (11%)0.73
Dyslipidemia, n (%)0 (0%)5 (19%)<0.01
Statin use, n (%)0 (0%)3 (11%)0.06
Diabetes mellitus, n (%)0 (0%)2 (7%)0.15
Hypertension, n (%)3 (7%)3 (11%)0.67
Tumor subtype, n (%)
 HR+22 (63%)12 (57%)
 HER2+9 (26%)6 (29%)
 Triple-negative4 (11%)3 (14%)0.86
Noninvasive or benign histology9 (20%)7 (25%)0.77
  • Abbreviation: HR, hormone receptor.